In Depth 24 Sep 2025 Eli Lilly’s strategy in motion: Beyond diabetes and obesity Delve into a biopharma giant’s strategy, Eli Lilly. This past year, the company secured regulatory milestones and strategic deals. September 24, 2025 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Sponsored by Lonza 9 Sep 2025 Advanced expression vector design to overcome challenges in developing multichain biotherapeutics Learn how multichain biotherapeutics like bispecific antibodies and Fc-fusion proteins overcome manufacturing challenges with advanced vectors and expression systems. September 9, 2025 - 8 minutesmins - By Jennifer Tsang Share WhatsApp Twitter Linkedin Email
Interview 3 Sep 2025 Radiopharma’s big year: Interview with RadioMedix CEO Dr. Delpassand As radiopharma is gaining momentum, read our interview with Dr. Delpassand, the CEO of RadioMedix’s, an established company of the field. September 3, 2025 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Webinars 1 Sep 2025Organoids in cancer research: Paving the way for faster drug development across cancer indications Discover how patient-derived organoids enable smarter, quicker oncology drug development. September 1, 2025 Share WhatsApp Twitter Linkedin Email
Best in Biotech 26 Aug 2025 Five biotech companies in South Korea you should know about Discover five South Korean biotechs that have received funding in recent years and are broadening R&D in various therapeutics areas. August 26, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 18 Aug 2025 mRNA vaccine funding cuts: the impact on U.S. healthcare and biotech The U.S. government announced funding cuts to mRNA vaccine research. What is the impact on American healthcare and biotech? August 18, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 13 Aug 2025 Injecting hope into skin cancer treatment: The promise of melanoma vaccines Discover how melanoma vaccines are gaining traction in the clinic and could soon become a treatment option for this deadly skin cancer. August 13, 2025 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 8 Aug 2025 Top biotech deals in July 2025 Learn about July 2025’s top biotech deals, featuring major collaborations in small molecules, antibodies, and drug delivery. August 8, 2025 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 6 Aug 2025 Fusion proteins attract funds and biopharma partnerships Fusion proteins have drawn investors these past months attracting dollars from deep pockets in the pursuit of commercial success. August 6, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 5 Aug 2025 10 oncology deals in 2025 spotlight where industry leaders are betting big Discover 10 key oncology deals that have been made so far in 2025, spotlighting where industry leaders are betting big. August 5, 2025 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 1 Aug 2025 Oncolytic virus therapy for cancer: what’s been going on in 2025? This past year has seen various developments in the field of oncolytic virus therapies – in fundraising and in the clinic. August 1, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 22 Jul 2025 Seven biotechs in Belgium making leaps in the clinic Meet the most successful biotech companies in Belgium, a country that makes a huge contribution to the biotech industry. July 22, 2025 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email